Follow

Idogen AB

Nasdaq First North GM Stockholm (Sweden)

Idogen is a Swedish biotech company engaged in developing tolerogenic cell therapies to prevent biological drugs, transplanted or body cells or tissues from being attacked by the patient's immune system. Its product IDO 8, treats patients with severe hemorrhagic disease.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0014428561
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Active
Amount of instruments
18 243 308
Currency
SEK
First trading date
12 Jun 2015
Exercise
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO5
SE0017232879
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO5
Status
Active
Amount of instruments
98 873 460
Currency
SEK
First trading date
02 Mar 2022
Terms
Three (3) warrants entitles the holder to subscribe for one (1) new share for the price which corresponds to 80 percent of the volume weighted average trading price during the period August 29, 2022 - September 9, 2022, however, not less than SEK 0.77 and not more than SEK 1.28 per share.
Update (23.02.2022): First trading day for warrants TO5 is March 2, 2022.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0006887386
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Archived
Amount of instruments
91 216 533
Currency
SEK
First trading date
12 Jun 2015
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0014428561
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Active
Amount of instruments
18 243 308
Currency
SEK
Market move
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO1
SE0006887394
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO1
Status
Archived
Amount of instruments
Currency
SEK
Trading period
12 Jun 2015 - 27 Sep 2016
Terms
One (1) warrant of series TO 1 entitles the owner to subscribe for one (1) share in the Company.
Update (21.09.2016): Reminder of the exercise of warrants of series TO 1.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO2
SE0009895618
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO2
Status
Archived
Amount of instruments
Currency
SEK
Trading period
31 Jul 2017 - 16 May 2018
Terms
One (1) warrant of series TO 2 entitles the owner to subscribe for one (1) new share in the Company.
Update (30.04.2018): Information regarding TO 2.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO3
SE0009895626
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO3
Status
Archived
Amount of instruments
Currency
SEK
Trading period
31 Jul 2017 - 28 Mar 2019
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company. The exercise price is set as 70 percent of the volume weighted average market price during 25 February - 15 March 2019. The price can not be lower than SEK 6.0 per share and not higher than SEK 13 per share.
Update (18.03.2019): Information regarding TO 3.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO4
SE0015194691
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO4
Status
Archived
Amount of instruments
9 121 654
Currency
SEK
Trading period
30 Dec 2020 - 01 Oct 2021
Terms
One (1) Unit consists of one (1) share and one (1) free warrant of series TO4. One (1) warrant entitles the holder to subscribe one (1) share at an exercise price corresponding to seventy (70) percent of the volume-weighted average price for the Company's share during the period from September 6, 2021 to September 17, 2021, however a minimum of SEK 2 and maximum SEK 5 per share.
Update (17.12.2020): Idogen announces the last day for trading in BTU and the first day for trading in warrants of series TO 4.
Update (21.09.2021): Start of subscription period.
Update (01.10.2021): Last trading day for warrants TO4.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO5
SE0017232879
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO5
Status
Active
Amount of instruments
98 873 460
Currency
SEK
First trading date
02 Mar 2022
Terms
Three (3) warrants entitles the holder to subscribe for one (1) new share for the price which corresponds to 80 percent of the volume weighted average trading price during the period August 29, 2022 - September 9, 2022, however, not less than SEK 0.77 and not more than SEK 1.28 per share.
Update (23.02.2022): First trading day for warrants TO5 is March 2, 2022.
Exercise
Sign in to buy
People
Christina Herder
CEO
Joakim Söderström
Chairman of the board
Christina Herder
Board member
Sharon Longhurst
Board member
Niklas Wallett
Board member
Agneta Edberg
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Scheelevägen 2
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
556756-8521
LEI code
549300ERF656YVUYXS32
First trade date
12 Jun 2015
Registration date
24 Apr 2008
Short name
IDOGEN

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More